KBKevin M. Bennett

Kevin M. Bennett

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Kevin M. Bennett has a total of 17 co-authors. Here are the top co-authors by number of shared publications:

  • Scott C. Beeman

    School of Biological and Health Systems Engineering, Arizona State University, Tempe, Arizona 85287-9709, USA

    2 shared publications
  • Alan P. Koretsky

    Laboratory of Functional and Molecular Imaging, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland, United States

    1 shared publication
  • Bradley D. Hann

    School of Biological and Health Systems Engineering, Arizona State University, Tempe, AZ, USA

    1 shared publication
  • Hua Zhou

    Renal Diagnostics and Therapeutics Unit, National Institute of Diabetes and Digestive and Kidney Disease, National Institutes of Health, Bethesda, Maryland

    1 shared publication
  • James P. Sumner

    Laboratory of Functional and Molecular Imaging, National Institute of Neurological Disease and Stroke, National Institutes of Health, Bethesda, Maryland

    1 shared publication
  • Jason Colomb

    School of Biological and Health Systems Engineering, Arizona State University, Tempe, Arizona, USA

    1 shared publication

Latest Publications

  • Open Access

    Toxicity, biodistribution, and ex vivo MRI detection of intravenously injected cationized ferritin

    by Scott C. Beeman, Joseph F. Georges, Kevin M. Bennett

    The goal of the work was to establish the toxicity and biodistribution of the superparamagnetic protein cationized ferritin (CF) after intravenous injection. Intravenously injected CF has been used to target the extracellular matrix with high specificity in the kidney glomerulus, allowing measurements of individual glomeruli using T‐weighted MRI. For the routine use of CF as an extracellular matrix‐specific tracer, it is important to determine whether CF is toxic. In this work, we investigated the renal and hepatic toxicity, leukocyte count, and clearance of intravenously injected CF. Furthermore, we studied CF labeling in several organs using MRI and immunohistochemistry. Serum measurements of biomarkers suggest that intravenous injection of CF is neither nephrotoxic nor hepatotoxic and does not increase leukocyte counts in healthy rats at a dose of 5.75 mg/100 g. In addition to known glomerular labeling, confocal and MRI suggest that intravenously injected CF labels the extracellular matrix of the hepatic sinusoid, extracellular glycocalyx of alveolar endothelial cells, and macrophages in the spleen. Liver T values suggest that CF is cleared by 7 days after injection. These results suggest that CF may serve as a useful contrast agent for detection of a number of structures and functions with minimal toxicity. Magn Reson Med, 2013.


  • Principles and emerging applications of nanomagnetic materials in medicine

    by Veronica Clavijo‐Jordan, Vikram D. Kodibagkar, Scott C. Beeman, Bradley D. Hann, Kevin M. Bennett

    The development of nanometer‐scale magnetic materials for biomedical applications spans the interface between the physical sciences and biology. Applications of these materials are rapidly becoming important in medicine and enable targeted therapies and diagnostics. At the same time, specific applications add focus to the development of novel magnetic materials and facilitate a deeper understanding of the physical mechanisms behind their function. This review presents a broad, nontechnical overview of the basis of magnetism in materials at the nanometer scale and describes how these materials are created, characterized, and used. Specific emerging applications in medical diagnostics and therapies are discussed, including cancer cell targeting for thermal ablation, tissue engineering, and three‐dimensional noninvasive molecular imaging. Challenges in these fields are discussed, including the toxicity and delivery of magnetic nanomaterials and the sensitivity of imaging and therapeutic techniques. The development of novel nanomagnetic nanomaterials should continue to accelerate as new applications are identified and researchers uncover new mechanisms to increase and modulate magnetism at the nanometer scale. WIREs Nanomed Nanobiotechnol 2012, 4:345–365. doi: 10.1002/wnan.1169 For further resources related to this article, please visit the WIREs website.


  • Open Access

    Self‐degrading, MRI‐detectable hydrogel sensors with picomolar target sensitivity

    by Jason Colomb, Katherine Louie, Stephen P. Massia, Kevin M. Bennett

    Nanostructured hydrogels have been developed as synthetic tissues and scaffolds for cell and drug delivery, and as guides for tissue regeneration. A fundamental problem in the development of synthetic hydrogels is that implanted gel structure is difficult to monitor noninvasively. This work demonstrates that the aggregation of magnetic nanoparticles, attached to specific macromolecules in biological and synthetic hydrogels, can be controlled to detect changes in gel macromolecular structure with MRI. It is further shown that the gels can be made to self‐degrade when they come into contact with a target molecule in as low as pM concentrations. The sensitivity of the gels to the target is finely controlled using an embedded zymogen cascade amplifier. These “MRI reporter gels” may serve as smart, responsive polymer implants, as tissue scaffolds to deliver drugs, or to detect specific pathogens in vivo. Magn Reson Med, 2010.


  • Open Access

    Simplified synthesis and relaxometry of magnetoferritin for magnetic resonance imaging

    by Veronica Clavijo Jordan, Michael R. Caplan, Kevin M. Bennett

    Magnetoferritin nanoparticles have been developed as high-relaxivity, functional contrast agents for MRI. Several previous techniques have relied on unloading native ferritin and re-incorporation of iron into the core, often resulting in a polydisperse sample. Here, a simplified technique is developed using commercially available horse spleen apoferritin to create monodisperse magnetoferritin. Iron oxide atoms were incorporated into the protein core via a step-wise Fe(II)Chloride addition to the protein solution under low O2 conditions; subsequent filtration steps allow for separation of completely filled and superparamagnetic magnetoferritin from the partially filled ferritin. This method yields a monodisperse and homogenous solution of spherical particles with magnetic properties that can be used for molecular magnetic resonance imaging. With a transverse per-iron and per-particle relaxivity of 78 mM−1 sec−1 and 404,045 mM−1 sec−1, respectively, it is possible to detect ∼10 nM nanoparticle concentrations in vivo. Magn Reson Med, 2010.


  • Open Access

    MRI of the basement membrane using charged nanoparticles as contrast agents

    by Kevin M. Bennett, Hua Zhou, James P. Sumner, Stephen J. Dodd, Nadia Bouraoud, Kent Doi, Robert A. Star, Alan P. Koretsky

    The integrity of the basement membrane is essential for tissue cellular growth and is often altered in disease. In this work a method for noninvasively detecting the structural integrity of the basement membrane, based on the delivery of cationic iron‐oxide nanoparticles, was developed. Cationic particles accumulate due to the highly negative charge of proteoglycans in the basement membrane. The kidney was used to test this technique because of its highly fenestrated endothelia and well‐established disease models to manipulate the basement membrane charge barrier. After systemic injection of cationic or native ferritin (CF or NF) in rats, ex vivo and in vivo MRI showed selective accumulation of CF, but not NF, causing a 60% reduction in signal intensity in cortex at the location of individual glomeruli. Immunofluorescence and electron microscopy demonstrated that this CF accumulation was localized to the glomerular basement membrane (GBM). In a model of GBM breakdown during focal and segmental glomerulosclerosis, MRI showed reduced single glomerular accumulation of CF, but a diffuse accumulation of CF in the kidney tubules caused by leakage of CF through the glomerulus. Cationic contrast agents can be used to target the basement membrane and detect the breakdown of the basement membrane in disease. Magn Reson Med 60:564–574, 2008.